NASDAQ: ORGS - Orgenesis Inc.

Rentabilité sur six mois: +774.23%
Secteur: Healthcare

Calendrier des promotions Orgenesis Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient.

Plus de détails
The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Выручка 0.0333
EBITDA -0.0209
Число акций ао 0.0251 млрд
P/S 1.48
P/BV 8.11
EV/EBITDA -3.01
Цена ао 0.8511
ISIN US68619K2042
Сайт https://www.orgenesis.com
Валюта usd
IPO date 2012-03-12
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Changement de prix par jour: -2.97% (4.37)
Changement de prix par semaine: -20% (5.3)
Changement de prix par mois: +613.8% (0.594)
Changement de prix sur 3 mois: +554.22% (0.6481)
Changement de prix sur six mois: +774.23% (0.485)
Changement de prix par an: +341.67% (0.96)
Evolution du prix sur 3 ans: -14.34% (4.95)
Evolution du prix sur 5 ans: -6.81% (4.55)
Evolution des prix depuis le début de l'année: +670.91% (0.55)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 268.68 1
P/BV -6.79 0
P/E 0 0
EV/EBITDA -3.04 0
Total: 2.5

Efficacité

Nom Signification Grade
ROA, % -380.44 0
ROE, % 263.84 10
Total: 3.33

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.4165 10
Total: 9.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -98.41 0
Rentabilité Ebitda, % 158.7 10
Rentabilité EPS, % 16.37 3
Total: 4.6
Plus de détails

Établissements Volume Partager, %
Vanguard Group Inc 924806 5.92
Knoll Capital Management, LLC 634738 4.06
Geode Capital Management, LLC 239264 1.53
Blackrock Inc. 127759 0.82
State Street Corporation 88659 0.57
Northern Trust Corporation 39122 0.25
Renaissance Technologies, LLC 38799 0.25
Bank Hapoalim B.M. 32052 0.21
Chapin Davis, Inc. 20000 0.13
Cambridge Investment Research Advisors Inc. 18330 0.12



Superviseur Titre d'emploi Paiement Année de naissance
Ms. Vered Caplan M.Sc. Chairperson of the Board, CEO & President 341.38k 1969 (55 années)
Prof. Sarah Ferber Ph.D. Founder & Chief Scientific Officer 268.32k 1954 (70 années)
Dr. Shimon Hassin Ph.D. Chief Technology Officer N/A
Mr. Victor Miller CFO, Secretary & Treasurer N/A 1970 (54 année)
Pierre Lammeretz Interim Chief Operating Officer N/A
Mr. Joseph Carpinelli Chief Financial Officer of Octomera N/A

Adresse: United States, Germantown. MD, 20271 Goldenrod Lane - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.orgenesis.com